#pancreaticcancer is a deadly disease. New #trial data shows early benefits for addition of a personalized #mRNA #vaccine to #adjuvantchemotherapy after resection of the tumor. This feature in Deutsche Welle discusses the implications with Nina Bhardwaj and Drew Weissman #Immunotherapy #oncology https://t.co/j81AOXjcJS
How mRNA could help fight deadly cancer | DW News

YouTube
#pancreaticcancer or #PancreaticDuctalAdenoCarcinoma is a still an extreme challenge in #Oncology. New insights on #adjuvantchemotherapy after resection and prior #neoadjuvant #chemotherapy suggest a new direction, but many questions remain...what type of chemotherapy or what type of patient is able to go through this treatment?
https://ja.ma/3iKFwNN
Adjuvant Chemotherapy in Patients With Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy

This cohort study of data from the National Cancer Database on patients with pancreatic adenocarcinoma who received neoadjuvant chemotherapy compares overall survival between those who received adjuvant chemotherapy and those who did not.

Largest study of its kind reveals adjuvant chemotherapy improves overall survival for pancreatic cancer patients

Today, the University of Colorado Cancer Center released new research that showcases chemotherapy treatment before and after surgery for pancreatic cancer as the most effective combination for patients.

Medical Xpress